Giordano Natasha 4
4 · PLx Pharma Inc. · Filed Mar 18, 2019
Insider Transaction Report
Form 4
PLx Pharma Inc.PLXP
Giordano Natasha
DirectorCEO
Transactions
- Award
Stock Option
2019-03-14+211,675→ 211,675 totalExercise: $5.79Exp: 2029-03-14→ Common Stock (211,675 underlying)
Footnotes (2)
- [F1]Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan.
- [F2]These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.